Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jin-Ho Lee has a total of 129 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Conducting Polymer–Nanomaterial Hybrids for Cancer Diagnostics

    by Mingyu Bae, Jin-Ho Lee

    Cancer continues to pose a major global burden because of the high incidence and mortality, underscoring the urgent need for innovative and highly sensitive diagnostic technologies. Conducting polymer–nanomaterial (CP–NM) hybrid biosensors have become promising platforms for cancer biomarker detection, integrating the redox-active and biocompatible nature of conducting polymers such as polyaniline (PANI), polypyrrole (PPy), and poly(3,4-ethylenedioxythiophene) (PEDOT) with the high surface area and charge transport properties of nanomaterials, including metallic nanoparticles, metal oxides, carbon-based nanostructures, and two-dimensional materials. The synergistic interfaces in these hybrids enable efficient electron transfer, signal amplification, and stable biomolecular immobilization, facilitating ultrasensitive and multiplexed detection of proteins, nucleic acids, and metabolites associated with tumor progression. This review highlights recent advances in CP–NM hybrid biosensors for cancer diagnostics, focusing on material design strategies, sensing mechanisms, and representative applications across electrochemical, optical, and mechanical modalities. Finally, key challenges and future perspectives are discussed, emphasizing the potential of CP–NM hybrid platforms to drive next-generation approaches for early cancer detection, therapeutic monitoring, and personalized healthcare.

  • Electrochemical Biosensor for Multiplexed Detection of Nucleic Acids Using a DNA Three-Way Junction with Metal Ion Intercalation

    by Seohee Park, Seokho Jung, Minyoung Lee, Taek Lee, Jin-Ho Lee, Jinho Yoon

    The multiplexed detection ability of biosensors can improve the accuracy of the early-stage disease diagnosis. Besides, an electrochemical technique is particularly well-suited for enabling such multiplexed target detection. The DNA three-way junction (3WJ) structure is capable of multiplexed detection of nucleic acids accompanying enhanced stability compared to a conventional double-stranded DNA structure. However, the introduction of redox active molecules for demonstration of electrochemical biosensing should be addressed for simple detection. In this study, we propose an electrochemical biosensor based on the 3WJ-metal ion intercalated DNA (3WJ-MID) for simultaneous detection of multiple DNA targets. To amplify the electrochemical response, an electrode with Au nanopatterns is employed as an electrode. As targets of this biosensor, human papillomavirus type 16 and 18 DNAs are detected for validation of multiplexed target detection. We expect that this biosensor can be used for the multiplexed detection of various nucleic acid biomarkers, including viral DNAs.


  • Fabrication of electrochemical biosensor with a CD36 aptamer and AuMoS2 heterolayer for tumor-derived exosome detection

    by Minyoung Lee, Yunseon Han, Hyunjun Park, Daehyeon Yoo, Hah Young Yoo, Jin-Ho Lee, Taek Lee


  • A rapid extended-gate field-effect transistor-type biosensor composed of a truncated DNA aptamer and UiO-66 metal–organic framework nanoparticles for HPIV detection in bronchoalveolar lavage fluid

    by Siyun Lee, Nayeon Kwon, Yejin Yoon, Jinho Yoon, Jong Geol Jang, Wonhwa Lee, Jin-Ho Lee, Chulhwan Park, Taek Lee

    A rapid EGFET biosensor employing UiO-66 MOF nanoparticles and HPIV aptamers enables sensitive detection of HPIV in BALF samples.


  • Open Access

    Small Toxic Molecule Detection and Elimination Using Molecularly Imprinted Polymers (MIPs)

    by Min Seok Kang, Jin-Ho Lee, Ki Su Kim

    Molecularly imprinted polymers (MIPs) provide selective, robust, and cost-effective platforms for the detection and removal of small toxic molecules in environmental, food, and biomedical contexts. This review offers a comprehensive overview of recent advancements in MIP-based systems, emphasizing critical design factors such as template selection, functional monomers, polymerization methods, and binding kinetics. The impact of these parameters on improving sensitivity, selectivity, and reusability is thoroughly examined. Additionally, current advantages, limitations, and enduring challenges are addressed. By highlighting emerging strategies and interdisciplinary innovations, this work aims to guide the development of more efficient and sustainable technologies for small-molecule toxin detection and remediation.


  • Amplification-Free CRISPR/Cas12a-Based Electrochemical Biosensor with Enhanced Sensitivity for Viral Detection

    by Yejin Lee, Jin-Ho Lee, Taek Lee, Minkyu Shin, Jinho Yoon

    To detect contagious viral nucleic acids, traditional biosensors often require target amplification steps or use fluorescence and Raman probes tagged on nucleic acids, which are time-consuming, complex, and expensive. Recently, the CRISPR/Cas12a has received the attraction for development of nucleic acid biosensors, beyond its conventional role-like gene editing, but the enhancement of the sensitivity of CRISPR/Cas-based biosensors is still required to simplify the biosensing steps. Here, we develop a CRISPR/Cas12a-based electrochemical biosensor for the detection of viral nucleic acids in a simple manner. The novel mismatch Ag probe (MAP), as a sensing probe, and the highly conductive gold electrode on indium tin oxide with a nano array (GELITION) are introduced that enable the amplification-free and ultrasensitive detection of nucleic acids using a CRISPR/Cas12a system. The biosensing ability of the developed biosensor is validated using human papillomavirus type 16 and 18 viral DNAs (HPV16 and HPV18), achieving a limit of detection (LOD) of 1 fM without amplification and complex steps. Our developed biosensor is expected to be applicable in detecting various viruses and could contribute to the early detection of future pandemics.


  • Open Access

    Plasmonic Biosensors in Cancer-Associated miRNA Detection

    by Nayoung Kim, Mingyu Bae, Euni Cho, Ki Su Kim, Jin-Ho Lee

    Cancer is one of the most lethal diseases and has distinct variants that affect over 60 organs in the human body. The necessity of advanced methodologies for the early diagnosis of cancer has grown over the past decades. Among various biomarkers, microRNAs (miRNAs) have emerged as highly specific and minimally invasive indicators for cancer detection, prognosis, and treatment monitoring. Their stability in biological fluids and their critical role in gene regulation make them valuable targets for diagnostic applications. Plasmonic biosensors have gained massive attention owing to their unique optical properties, such as surface plasmon resonance, making them promising tools for the sensitive and selective analysis of cancer-associated biomarkers. In contrast to previous reviews, this work offers a comprehensive overview of advancements from approximately the past five years, particularly in the detection of cancer-associated miRNAs. It emphasizes emerging plasmonic sensing strategies, integration with novel nanomaterials, and enhanced signal amplification techniques. By focusing on these recent innovations, this review provides new insights into the potential of plasmonic biosensors to improve cancer diagnosis and treatment.


  • Open Access

    Recent Advances in Electrochemical Biosensors for Neurodegenerative Disease Biomarkers

    by Mingyu Bae, Nayoung Kim, Euni Cho, Taek Lee, Jin-Ho Lee

    Neurodegenerative diseases, such as Parkinson’s disease (PD) and Alzheimer’s disease (AD), represent a growing global health challenge with overlapping biomarkers. Key biomarkers, including α-synucleins, amyloid-β, and Tau proteins, are critical for accurate detection but are often assessed using conventional methods like enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR), which are invasive, costly, and time-intensive. Electrochemical biosensors have emerged as promising tools for biomarker detection due to their high sensitivity, rapid response, and potential for miniaturization. The integration of nanomaterials has further enhanced their performance, improving sensitivity, specificity, and practical application. To this end, this review provides a comprehensive overview of recent advances in electrochemical biosensors for detecting neurodegenerative disease biomarkers, highlighting their strengths, limitations, and future opportunities. By addressing the challenges of early diagnosis, this work aims to stimulate interdisciplinary innovation and improve clinical outcomes for neurodegenerative disease patients.


  • Open Access

    Flexible Electrochemical Biosensor Using Nanostructure-Modified Polymer Electrode for Detection of Viral Nucleic Acids

    by Jiyu Han, Yejin Lee, Jin-Ho Lee, Jinho Yoon

    In the biosensor field, the accurate detection of contagious disease has become one of the most important research topics in the post-pandemic period. However, conventional contagious viral biosensors normally require chemical modifications to introduce the probe molecules to nucleic acids such as a redox indicator, fluorescent dye, or quencher for biosensing. To avoid this complex chemical modification, in this research, mismatched DNA with an intercalated metal ion complex (MIMIC) is employed as the probe sequence. In addition, the MIMIC is fabricated on a lithography-assisted nanostructure-modified flexible polymer electrode. On this flexible electrode, as a proof-of-concept study, a human papillomavirus (HPV-16 and -18) was detected by the MIMIC with a high accuracy. The developed biosensor exhibits an ultrasensitive ability to detect HPV in viral DNA without target amplification and chemical modifications in a simple preparation manner. Moreover, it retains its nanostructures and high conductivity after bending. In conclusion, the use of the proposed biosensor suggests a novel approach to developing an ultrasensitive and flexible biosensor for the detection of important biomarkers in a simple manner that can be applied in point-of-care testing.


  • Open Access

    Nano/Micro Biosensors for Biomedical Applications

    by Jin-Ho Lee, Ki Su Kim

    Advances in nano/micro technologies in recent years have significantly improved biosensors in terms of their viability for biomedical purposes, from diagnostic to therapeutic applications, allowing for effective early detection and personalized treatment modalities